Dr. Mark Brian Szymanski, M.D. Pathology - Dermatopathology Medicare: Medicare Enrolled Practice Location: 405 S State St, Clarks Summit, PA 18411 Phone: 570-586-4400 Fax: 570-587-5531 |
News Archive
Genomic Health, Inc. today announced results from a clinical survey evaluating the impact of the Oncotype DX® Recurrence Score® result on physicians' adjuvant treatment recommendations for patients with node-positive, hormone receptor-positive breast cancer.
Sequella, Inc., a clinical-stage company focused on commercializing novel drugs for treatment of life-threatening infectious diseases, announced it has signed an agreement with the Ludwig-Maximilians-University (LMU) of Munich to coordinate a European Union grant for Phase 2 clinical trials of SQ109 in adult pulmonary tuberculosis (TB) in seven sites in Africa.
Kaiser Health News provides a fresh take on health policy developments with "Aerodynamic Drag" by Lisa Benson.
There is significant disparity between 'richer' and 'poorer' countries in terms of access to biological treatments for rheumatoid arthritis (RA), according to results from a multinational study across four continents presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. Furthermore, findings from a separate study show that RA patients report the severity of their disease in the same way, irrespective of the country where they live.
Referencing the phrase "impatient optimists," coined by the Bill & Melinda Gates Foundation, Aminu Magashi, an adviser for the USAID-funded Targeted States High Impact Project, writes in Nigeria's Daily Trust, "Although in many developing countries, the Millennium Development Goal (MDG) 5 of improving maternal health by 2015 will not be achieved, we should all be optimistic and impatient to continue doing what we can to reduce the burden of maternal death which will positively reduce the burden of newborn and child mortality."
› Verified 4 days ago